NCT01846052View on ClinicalTrials.gov

Clinical and Genetic Characterization of Individuals With Achromatopsia

CompletedOBSERVATIONAL
Enrollment

56

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Achromatopsia
Trial Locations (5)

32607

VitreoRetinal Associates, Gainesville

33136

Bascom Palmer Eye Institute, Miami

53226

Medical College of Wisconsin, Milwaukee

60608

Pangere Center for Inherited Retinal Diseases, The Chicago Lighthouse for People Who Are Blind or Visually Imp, Chicago

97239

Casey Eye Institute, Oregon Health & Science University, Portland

Sponsors
All Listed Sponsors
collaborator

National Eye Institute (NEI)

NIH

lead

Beacon Therapeutics

INDUSTRY

NCT01846052 - Clinical and Genetic Characterization of Individuals With Achromatopsia | Biotech Hunter | Biotech Hunter